(Q35246094)

7 August 2017

1 reference

title

Thyroid-associated ophthalmopathy. (English)

1 reference

7 August 2017

1

Weetman AP

1 reference

7 August 2017

publication date

1 January 1992

1 reference

7 August 2017

1 reference

7 August 2017

volume

12

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

215-222

1 reference

Endocrine Ophthalmopathy: Current Ideas Concerning Etiology, Pathogenesis, and Treatment

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08916939209148462

Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209148462

Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209148462

Major histocompatibility complex (MHC) factors predisposing to and protecting against Graves' eye disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209148462

Analysis of HLA-DQB and HLA-DPB alleles in Graves' disease by oligonucleotide probing of enzymatically amplified DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209148462

Genetic differences shown by HLA typing among Japanese patients with euthyroid Graves' ophthalmopathy, Graves' disease and Hashimoto's thyroiditis: genetic characteristics of euthyroid Graves' ophthalmopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209148462

Thyroid Diseases after Treatment of Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209148462

Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209148462

T and B cell reactivity to extraocular and skeletal muscle in Graves' ophthalmopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209148462

Cross-reaction of eye muscle antibodies with thyroid tissue in thyroid-associated ophthalmopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209148462

Cloning and sequencing of a novel 64-kDa autoantigen recognized by patients with autoimmune thyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209148462

Thyroid-associated ophthalmopathy--a model for the association of organ-specific autoimmune disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209148462

Failure to detect complement-mediated antibody-dependent cytotoxicity against human orbital tissue cells in the serum of patients with thyroid-associated ophthalmopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209148462

Biological activity of autoantibodies associated with Graves' dermopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209148462

Neonatal Graves' disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209148462

Increased induction of HLA-DR by interferon-gamma in cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial dermopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209148462

Octreotide and Graves' ophthalmopathy and pretibial myxoedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209148462

10.3109/08916939209148462

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference